Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone

Blood

Volumn 88, Issue 12, 1996, Pages 4659-4666

  Puthier, Denis ^b   Bataille, Régis ^a   Barillé, Sophie ^b   Mellerin, Marie Paule ^b   Harousseau, Jean Luc ^b   Ponzio, Anne ^b   Robillard, Nelly ^b   Wijdenes, John ^b   Amiot, Martine ^b  

^a INSTITUT DE BIOLOGIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL DERIVATIVE; DEXAMETHASONE; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; MONOCLONAL ANTIBODY; ONCOSTATIN M; SEOCALCITOL;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; COMPLICATION; CYTOSTASIS; DNA CONTENT; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPERCALCEMIA; MYELOMA CELL; PLASMA CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0029956612     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.12.4659.bloodjournal88124659     Document Type: Article

References (30)

1. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83, 1988
2. Klein B, Zhang X G, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Bataille R: Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73:517, 1989
3. Kishimoto T, Akira S, Narazaki M, Taga T: Interleukin-6 family of cytokines and gp130. Blood 86:1243, 1995
4. Klein B, Zhang XG, Lu ZY, Bataille R: Interleukin-6 in human multiple myeloma. Blood 85:863, 1995
5. Klein B, Wijdenes J, Zhang XG, Jourdan M, Boiron JM, Brochier J, Liautard J, Merlin M, Clement C, Marcel-Fournier B, Lu ZY, Mannoni P, Sany J, Bataille R: Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 78:1198, 1991
6. Bataille R, Barlogie B, Lu ZY, Rossi JF, Lavabre T, Wijdenes J, Beck T, Brochier J, Klein B: Biological effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood 86:685, 1995
7. Klein B, Lu ZY, Bataille R: Clinical applications of IL-6 inhibitors. Res Immunol 46:774, 1992
8. 3 receptor mediated modulation of the human myeloma cell line RPMI 8226. Cancer Res 48:1213, 1988
9. 3 analogs: Effects on leukemic clonal growth differentiation and on serum calcium levels. Leuk Res 19:65, 1995
10. Distelhorst CW, Benutto BM, Bergamini RA: Effect of cell cycle position on dexamethasone binding by mouse and human lymphoid cell lines: Correlation between an increase in dexamethasone binding during S phase and dexamethasone sensitivity. Blood 63:105, 1984
11. Alexanian R, Dimopoulos MA, Delasalle K, Barlogie B: Primary dexamethasone treatment of multiple myeloma. Blood 80:887, 1992
12. Juge-Morineau N, François S, Puthier D, Godard A, Bataille R, Amiot M: The gp130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the antiproliferative effect of dexamethasone on human myeloma cells. Br J Haematol 90:707, 1995
13. Pellat-Deceunynck C, Bataille R, Robillard N, Harousseau JL, Rapp MJ, Juge-Morineau N, Wijdenes J, Amiot M: Expression of CD28 and CD40 in human myeloma cells: A comparative study with normal plasma cells. Blood 84:2597,1994
14. Zamai L, Falcieri E, Zauli G, Cataldi A, Vitale M: Optimal detection of apoptosis by flow cytometry depends on cell morphology. Cytometry 14:891,1993
15. Hardin J, Mac Leod S, Grigorieva I, Chang R, Barlogie B, Xiao H, Epstein J: Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood 84:3063, 1994
16. Wijdenes J, Heinrich C, Müller-Newen G, Roche C, Gu Z-J, Clement C, Klein B: Interleukin-6 signal transducer gp130 has specific binding sites for differents cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Eur J Immunol 25:3474, 1995
17. Murakami T, Togawa A, Satch H, Katoh M, Imamma Y, Ohsawa N, Takaku F: Glucocorticoid receptor in multiple myeloma. Eur J Haematol 39:54, 1987
18. Gomi M, Moriwaki K, Katagiri S, Kurata J, Thompson EB: Glucocorticoid effects on myeloma cells in culture: Correlation of growth inhibition with induction of glucocorticoid receptor messenger RNA. Cancer Res 50:1873, 1990
19. Ishikawa H, Tanaka H, Iwato K, Tanabe O, Asaoku H, Nobuyoshi M, Yamamoto I, Kawano M, Kuramoto A: Effect of glucocorticoids on the biologic activities of myeloma cells: Inhibition of interleukin-1β osteoclast activating factor-induced bone resorption. Blood 75:715, 1990
20. 3 analogues is not mediated by inhibition of the AP-1 pathway but may be related to promoter selectivity. Oncogene 11:1853, 1995
21. Mc Elwain MC, Russell DM, Modzelewski RA, Trump DC, Smith DC, Uskokovic MR, Johnson CS: Enhanced anti-tumor activity of 1,25-dihydrocholecalciferol by dexamethasone in squamous cell carcinoma. Proc Am Assoc Cancer Res 36:273, 1995
22. 3 in HL60 cells. Cancer Res 56:264, 1996
23. 3 in human breast cancer cells. Cancer Res 48:2734, 1988
24. Snyers L, de Wit L, Content J: Glucocorticoid up-regulation of high affinity interleukin-6 receptors on human epithelial cells. Proc Nat Acad Sci USA 87:2838, 1990
25. Pietako D, Zohlnhöfer D, Graeve L, Fleischer D, Stoyan T, Schooltink H, Rose-Jolin S, Heinrich PC: The hepatic interleukin-6 receptor. Studies on its structure and regulation by phorbol 12-myristate 13-acetate-dexamethasone. J Biol Chem 25:4250, 1993
26. Udagawa N, Takahashi N, Katagiri T, Tamma T, Wada S, Findlay DM, Martin J, Hirota H, Taga T, Kishimoto T, Suda T: Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoclastic cells but not on osteoclast progenitors. J Exp Med 182:1461, 1995
27. Chen YH, Dessi P, Shiao RT, Lavelle D, Haleem A, Chen J: Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: Synergy through modulation of interleukin-6 autocrine loop at multiple sites. Blood 87:314, 1996
28. Miyaura C, Jin CH, Yamaguchi Y, Tomida M, Hozumi M, Matsuda T, Hirano T, Kishimoto T, Suda T: Production of inlerleukin-6 and its relation to the macrophage differentiation of mouse myeloid leukemia cells (M1) treated with differentiation-inducing factor and 1α, 25-dihydroxyvitamin D3. Biochem Biophys Res Commun 158:660, 1989
29. Colston KW, Mackay AG, James SY, Binderup L, Chandler S, Coomber RC: EB 1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 44:2273, 1992
30. Kornbluth J: Modulation of myeloma susceptibility to cell-mediated cytolysis by cytokines, in Bataille R, Harousseau JL (eds): Proceedings of the Fifth International Myeloma Workshop, Nantes-La Baule, France, September 11-13, 1995, 3:59, 1995